TITLE

Medtronic, Scil to combine forces on bone regeneration

PUB. DATE
June 2008
SOURCE
Proofs;Jun2008, Vol. 91 Issue 3, p47
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article announces the partnership of Medtronic Inc. and Scil Technology GmbH on the development of Scil's biologic recombinant human Growth and Differentiating Factor 5 (rhGDF-5). The agreement involves the licensing and supply of rhGDF-5 dental regenerative technology, which will be used in bone regeneration for treatment of periodontal disease and implant placement. Details of the agreement, such as Scil's responsibility for research and development (R&D) and Medtronic for clinical trials and regulatory approvals, are mentioned.
ACCESSION #
33160979

 

Related Articles

  • Scil, Pfizer Enter $250M Deal for Preclinical Osteo Drug. Sheridan, Cormac // BioWorld International;1/23/2008, Vol. 13 Issue 4, p1 

    The article reports on the decision of Scil Technology GmbH and Pfizer Inc. to enter into a $250 million deal for the development of a preclinical osteoarthritis drug. Under the agreement, Scil Technology would receive royalties on product sales. The company will be out-licensing rights to...

  • Scil, Pfizer Enter $250M Deal for Preclinical Osteo Drug. Sheridan, Cormac // BioWorld Today;1/17/2008, Vol. 19 Issue 12, p1 

    The article reports on the license deal signed between Scil Technology GmbH and Pfizer Inc. The deal involved the out-licensing of rights to cartilage-derived retinoic acid sensitive protein (CD-RAP), a growth factor expressed in cartilage tissue. CD-Rap is an 11-kilo Dalton secreted protein...

  • Agreements.  // Medical Device Daily;4/30/2008, Vol. 12 Issue 84, p5 

    The article reports on the development, licensing and supply agreement signed by Medtronic and Scil Technology. The focus of the agreement is Scil's biologic recombinant human Growth and Differentiating Factor 5 (rhGDF-5) dental technology for use in bone regeneration for dental implant...

  • Scil, Pfizer in $250M Deal for Preclinical Osteo Drug.  // Bioworld Week;1/21/2008, Vol. 16 Issue 3, p1 

    The article reports that Scil Technology GmbH could earn as much as $250 million in up-front and milestone payments from Pfizer Inc. by out-licensing rights to cartilage-derived retinoic acid sensitive protein. The sales potential is substantial since Scil Technology is positioning CD-Rap as a...

  • Scil Technology to Bank $239M+ In Osteoarthritis Deal with Sanofi. Moran, Nuala // BioWorld Today;12/21/2011, Vol. 22 Issue 245, p1 

    The article reports on the partnership agreement signed by Scil Technology GmbH with Sanofi SA for the commercialization of its protein therapy for osteoarthritis. According to Christian Nafe of Scil Technology, it will 10 years to trigger all of the milestone payments in the agreement. Scil...

  • Scil Technology to Bank $239M+ In Osteoarthritis Deal with Sanofi. Moran, Nuala // BioWorld International;12/21/2011, Vol. 16 Issue 51, p1 

    The article reports on a deal entered into by Scil Technology GmbH with Sanofi as its commercial partner for its protein therapy for osteoarthritis. According to Christian Nafe, chief executive officer (CEO) of Scil Technology, it will take 10 years to trigger all the milestone payments. Human...

  • In Detail.  // BioPharm International;Feb2008, Vol. 21 Issue 2, p14 

    The article offers news briefs related to developments in the U.S. pharmaceutical industry. Pfizer Inc. and Scil Technology GmbH will develop the cartilage specific growth factor CD-RAP, a polypeptide that plays a role during cartilage formation in embryonic development. Nektar Therapeutics will...

  • Medtronic purchases heart-products firm. Japsen, Bruce // Modern Healthcare;4/4/94, Vol. 24 Issue 14, p84 

    Reports on Medtronic's purchase of heart products manufacturer DLP. Purchase price; Other cardiac-device firm purchase by Medtronic; Schedule of Medtronic shareholders meeting to vote on the transaction; Products manufactured by Medtronic.

  • Titanium ceramic composite cervical device protects spine.  // Advanced Materials & Processes;Jan2007, Vol. 165 Issue 1, p64 

    The article evaluates the Prestige LP Cervical Disc from Medtronic Inc.

Share

Read the Article

Courtesy of

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics